(MNPR) Monopar Therapeutics - Performance 1067.9% in 12m
Compare MNPR with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-0.97%
#36 in Group
Rel. Strength
99.96%
#4 in Universe
Total Return 12m
1067.85%
#2 in Group
Total Return 5y
-2.49%
#40 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: MNPR (1067.9%) vs XBI (-8.9%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| ABBV NYSE AbbVie |
-18.4% | 8.88% | 153% | 75.1 | 14.6 | 0.38 | -49.6% | -19% |
| UTHR NASDAQ United Therapeutics |
-9.36% | 20.2% | 168% | 11.8 | 10.6 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
-0.68% | 26.4% | 40.5% | 24.7 | 20.3 | 1.8 | 27.1% | - |
| AMGN NASDAQ Amgen |
-13% | 8.75% | 36.7% | 38.4 | 14.1 | 0.99 | -18.8% | -20% |
| LONN SW Lonza |
-4.4% | 6.49% | 31% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
| BIM PA Biomerieux |
-1.64% | 15.9% | 7.58% | 31.5 | 25.4 | 1.47 | -58.7% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
-7.58% | -23.5% | -0.25% | 29.1 | 20.7 | 0.27 | 61.5% | 31.6% |
| KMDA NASDAQ Kamada |
-2.4% | 31.1% | -2.82% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
Performance Comparison: MNPR vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for MNPR
| Total Return (including Dividends) | MNPR | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 15.19% | -11.88% | -5.89% |
| 3 Months | 24.97% | -16.10% | -12.45% |
| 12 Months | 1067.85% | -8.91% | 6.72% |
| 5 Years | -2.49% | -19.71% | 101.06% |
| Trend Score (consistency of price movement) | MNPR | XBI | S&P 500 |
| 1 Month | -36.9% | -80.4% | -74.5% |
| 3 Months | -33.4% | -89.8% | -88.2% |
| 12 Months | 87.4% | -26.1% | 66.1% |
| 5 Years | -58.4% | -52.8% | 84.3% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #11 | 30.7% | 22.4% |
| 3 Month | #8 | 49.0% | 42.7% |
| 12 Month | #3 | 1,182% | 994% |
| 5 Years | #41 | 21.5% | -51.5% |
FAQs
Does MNPR Monopar Therapeutics outperforms the market?
Yes,
over the last 12 months MNPR made 1067.85%, while its related Sector, the SPDR S&P Biotech (XBI) made -8.91%.
Over the last 3 months MNPR made 24.97%, while XBI made -16.10%.
Over the last 3 months MNPR made 24.97%, while XBI made -16.10%.
Performance Comparison MNPR vs Indeces and Sectors
MNPR vs. Indices MNPR is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 14.9% | 21.1% | 629% | 1,061% |
| US NASDAQ 100 | QQQ | 15.7% | 21.5% | 630% | 1,062% |
| US Dow Jones Industrial 30 | DIA | 16.1% | 21.0% | 629% | 1,063% |
| German DAX 40 | DAX | 9.52% | 24.6% | 612% | 1,050% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 14.2% | 22.7% | 627% | 1,062% |
| Hongkong Hang Seng | HSI | 10.6% | 25.0% | 628% | 1,052% |
| India NIFTY 50 | INDA | 10.5% | 10.4% | 627% | 1,065% |
| Brasil Bovespa | EWZ | 11.3% | 20.3% | 626% | 1,077% |
MNPR vs. Sectors MNPR is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 14.6% | 20.9% | 620% | 1,054% |
| Consumer Discretionary | XLY | 15.8% | 19.1% | 626% | 1,059% |
| Consumer Staples | XLP | 11.6% | 12.0% | 619% | 1,054% |
| Energy | XLE | 10.2% | 25.3% | 628% | 1,078% |
| Financial | XLF | 13.5% | 19.7% | 621% | 1,049% |
| Health Care | XLV | 14.5% | 22.6% | 631% | 1,068% |
| Industrial | XLI | 13.8% | 19.9% | 629% | 1,062% |
| Materials | XLB | 13.2% | 21.8% | 636% | 1,075% |
| Real Estate | XLRE | 9.54% | 18.1% | 628% | 1,051% |
| Technology | XLK | 16.2% | 24.1% | 636% | 1,069% |
| Utilities | XLU | 11.6% | 15.6% | 623% | 1,043% |
| Aerospace & Defense | XAR | 13.2% | 15.2% | 619% | 1,044% |
| Biotech | XBI | 11.3% | 27.1% | 644% | 1,077% |
| Homebuilder | XHB | 13.9% | 22.0% | 647% | 1,077% |
| Retail | XRT | 13.2% | 17.3% | 634% | 1,072% |